|
Gene description for CAPS2 |
| Gene name |
calcyphosine 2 |
| Gene symbol |
CAPS2 |
| Other names/aliases |
UG0636c06 |
| Species |
Homo sapiens |
Database cross references - CAPS2 |
| ExoCarta |
ExoCarta_84698 |
| Vesiclepedia |
VP_84698 |
| Entrez Gene |
84698 |
| HGNC |
16471 |
| MIM |
607724 |
| UniProt |
Q9BXY5
|
CAPS2 identified in sEVs derived from the following tissue/cell type |
|
Urine
|
21595033
|
|
Urine
|
21595033
|
|
Urine
|
21595033
|
Gene ontology annotations for CAPS2 |
|
|
Experiment description of studies that identified CAPS2 in sEVs |
| 1 |
| Experiment ID |
193 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD63|CD9
|
Enriched markers |
|
✔
PHB
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
21595033
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. |
| Authors |
"Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, Kwon TH, Kim CD, Park SH, Hwang D, Kim YL, Baek MC." |
| Journal name |
Proteomics
|
| Publication year |
2011 |
| Sample |
Urine |
| Sample name |
Urine - Normal |
| Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 2 |
| Experiment ID |
194 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✘
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
21595033
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. |
| Authors |
"Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, Kwon TH, Kim CD, Park SH, Hwang D, Kim YL, Baek MC." |
| Journal name |
Proteomics
|
| Publication year |
2011 |
| Sample |
Urine |
| Sample name |
Urine - Patients of basement membrane nephropathy |
| Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 3 |
| Experiment ID |
195 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✘
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
21595033
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. |
| Authors |
"Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, Kwon TH, Kim CD, Park SH, Hwang D, Kim YL, Baek MC." |
| Journal name |
Proteomics
|
| Publication year |
2011 |
| Sample |
Urine |
| Sample name |
Urine - Patients of early IgA nephropathy |
| Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
Protein-protein interactions for CAPS2 |
| |
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
|
No interactions are found.
|
|
Pathways in which CAPS2 is involved |
|
No pathways found
|
|
|